Scientists at the Texas Biomedical Research Institute have discovered a medication that significantly decreases the growth of tuberculosis (TB), especially in drug-resistant bacteria. The medication, which is a combination of two molecules, has been successful in initiating natural cell death processes in TB-infected human cells. TB kills over 1.6 million people annually, and drug resistance is making treatment more difficult. The researchers believe that host-directed therapies, like this medication, can be a game-changer for infectious diseases.
Scientists at the Texas Biomedical Research Institute have discovered a medication that significantly decreases the growth of tuberculosis (TB), especially in drug-resistant bacteria. The medication, which is a combination of two molecules, has been successful in initiating natural cell death processes in TB-infected human cells. TB kills over 1.6 million people annually, and drug resistance is making treatment more difficult. The researchers believe that host-directed therapies, like this medication, can be a game-changer for infectious diseases.
We use cookies to improve your experience on our site and to show you relevant advertising. To find out more, read our updated privacy policy and cookie policy
Through RSS Feeds 
Scientists at the Texas Biomedical Research Institute have discovered a medication that significantly decreases the growth of tuberculosis (TB), especially in drug-resistant bacteria. The medication, which is a combination of two molecules, has been successful in initiating natural cell death processes in TB-infected human cells. TB kills over 1.6 million people annually, and drug resistance is making treatment more difficult. The researchers believe that host-directed therapies, like this medication, can be a game-changer for infectious diseases. 
